Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jiangxi Rimag Group Co., Ltd. Class H ( (HK:2522) ) has provided an announcement.
Jiangxi Rimag Group Co., Ltd. announced the results of its 2024 Annual General Meeting held on April 23, 2025, which combined a physical and virtual format. The meeting saw a significant shareholder turnout, with resolutions regarding the approval of the 2024 annual report, work reports from the Board and Supervisors, profit distribution plan, and auditor re-appointment all passing with overwhelming support. Additionally, special resolutions granting the Board mandates to issue new shares and repurchase H shares were also approved, indicating strong shareholder confidence in the company’s strategic direction.
More about Jiangxi Rimag Group Co., Ltd. Class H
Jiangxi Rimag Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating with limited liability. The company is listed on the Hong Kong Stock Exchange and is involved in the medical imaging industry, focusing on providing diagnostic services.
YTD Price Performance: -69.30%
Average Trading Volume: 3,206,210
Technical Sentiment Signal: Strong Buy
Learn more about 2522 stock on TipRanks’ Stock Analysis page.